Skip to main content
. 2022 Aug 23;14(5):479–493. doi: 10.4168/aair.2022.14.5.479

Table. Demographic data of the study subjects.

Variables Healthy controls (n = 26) Asthmatic patients (n = 52) P value NSA (n = 41) SA (n = 11) P value
Age (yr) 40.1 ± 9.8 46.1 ± 14.5 0.061 44.4 ± 14.9 52.4 ± 11.5 0.108
Female sex (%) 26.9 61.5 0.086 61.0 63.6 0.872
Atopy (%) 35.0 48.1 0.073 51.2 36.4 0.381
Ex-smoker (%) 25.5 38.5 0.240 18.2 27.5 0.530
Baseline FEV1 (%) ND 80.6 ± 23.2 ND 84.3 ± 20.0 66.4 ± 29.6 0.021
PC20 (mg/mL) ND 1.6 ± 2.0 ND 1.8 ± 2.1 1.0 ± 0.7 0.398
Total IgE (kU/L) 115.3 ± 184.6 275.6 ± 308.4 0.027 181.7 ± 147.0 300.7 ± 335.9 0.260
TEC (cells/μL) ND 323.4 ± 273.0 ND 304.9 ± 254.1 391.7 ± 339.5 0.443
Sputum Eos (%) ND 26.1 ± 31.4 ND 24.3 ± 31.9 31.7 ± 30.6 0.525

P values were obtained by Pearson’s χ2 test for categorical variables and by Student’s t-test for continuous variables.

NSA, nonsevere asthma; SA, severe asthma; FEV1, forced expiratory volume in 1 second; methacholine PC20, the provocative concentration of methacholine required to cause a 20% fall in FEV1; IgE, immunoglobulin E; TEC, total eosinophil count; Eos, eosinophil; ND, no data.